These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 38727281)

  • 21. The application of iPSCs in Parkinson's disease.
    Jarbæk Nielsen JJ; Lillethorup TP; Glud AN; Hedemann Sørensen JC; Orlowski D
    Acta Neurobiol Exp (Wars); 2020; 80(3):273-285. PubMed ID: 32990285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells.
    Kim Y; Ju JH
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
    Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
    Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
    Costamagna G; Comi GP; Corti S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interdisciplinary approaches to brain organoid biology].
    Kodera T; Osakada F
    Nihon Yakurigaku Zasshi; 2023; 158(1):64-70. PubMed ID: 36596494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Cytomegalovirus Compromises Development of Cerebral Organoids.
    Brown RM; Rana PSJB; Jaeger HK; O'Dowd JM; Balemba OB; Fortunato EA
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney organoids in translational medicine: Disease modeling and regenerative medicine.
    Miyoshi T; Hiratsuka K; Saiz EG; Morizane R
    Dev Dyn; 2020 Jan; 249(1):34-45. PubMed ID: 30843293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy.
    Rispoli P; Scandiuzzi Piovesan T; Decorti G; Stocco G; Lucafò M
    WIREs Mech Dis; 2024; 16(1):e1630. PubMed ID: 37770042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Evolving Role of Induced Pluripotent Stem Cells and Cerebral Organoids in Treating and Modeling Neurosurgical Diseases.
    Jovanovich N; Habib A; Kodavali C; Edwards L; Amankulor N; Zinn PO
    World Neurosurg; 2021 Nov; 155():171-179. PubMed ID: 34454068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.
    Jusop AS; Thanaskody K; Tye GJ; Dass SA; Wan Kamarul Zaman WS; Nordin F
    Front Mol Neurosci; 2023; 16():1173433. PubMed ID: 37602192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
    Qian L; Tcw J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids.
    Qu Y; Han B; Gao B; Bose S; Gong Y; Wawrowsky K; Giuliano AE; Sareen D; Cui X
    Stem Cell Reports; 2017 Feb; 8(2):205-215. PubMed ID: 28132888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery.
    Costamagna G; Andreoli L; Corti S; Faravelli I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
    Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
    Zhu L; Liu K; Feng Q; Liao Y
    Stem Cell Rev Rep; 2022 Dec; 18(8):2593-2605. PubMed ID: 35525908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.
    Okano H; Morimoto S
    Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Generation of Multiple Ocular Lineages from Human Pluripotent Stem Cells and Its Application to Regenerative Medicine].
    Hayashi R
    Yakugaku Zasshi; 2021; 141(1):55-60. PubMed ID: 33390448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in iPSC technologies involving cardiovascular and neurodegenerative disease modeling.
    Csöbönyeiová M; Danišovič Ľ; Polák Š
    Gen Physiol Biophys; 2016 Jan; 35(1):1-12. PubMed ID: 26492069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.